Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2006-08-08
2006-08-08
Saeed, Kamal (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S568000, C562S471000, C562S472000, C560S017000
Reexamination Certificate
active
07087644
ABSTRACT:
The invention relates to compounds of formula (I) as well as the salts and stereoisomers thereofwherein the several variable groups are as defined in the specification and claims. Processes for making these materials, pharmaceutical compositions containing them, and methods for using them for treatment of cardiovascular disorders are also disclosed and claimed.
REFERENCES:
patent: 3646145 (1972-02-01), Thiele
patent: 4154837 (1979-05-01), Heider et al.
patent: 4483867 (1984-11-01), Svahn et al.
patent: 4629737 (1986-12-01), Cantello
patent: 19642255 (1998-04-01), None
patent: 0053434 (1982-06-01), None
patent: 0341551 (1989-11-01), None
patent: 0345068 (1989-12-01), None
patent: 9300359 (1993-01-01), None
patent: 9816223 (1998-04-01), None
patent: 9816507 (1998-04-01), None
patent: 9823619 (1998-06-01), None
Ko, F., Wu, C., Kuo, S., Lee, F., Teng, C., “YC-1, A Novel Activator of Platelet Guanylate Cyclase”, Blood , 84: 4226-4233 (1994).
Mulsch, A., Bauersachs, J., Schafer, A., Stasch, J., Kast, R., Busse, R., “Effect of YC-1, An NO-Independent, Superoxide-Sensitive Stimulator of Soluble Guanylyl Cyclase, On Smooth Muscle Responsiveness to Nitrovasodilators”, Br. J. Pharmacol., 120: 681-689 (1997).
Glass, D., Frey, W., Carr, D., Goldberg, N., “Stimulation of Human Platelet Guanylate Cyclase by Fatty Acids”, J. Biol. Chem., 252: 1279-1285 (1977).
Pettibone, D., Sweet, C., Risley, E., Kennedy, T., “A Structurally Novel Stimulator of Guanylate Cyclase With Long-Lasting Hypotensive Activity in the Dog”, Eur. J. Pharmacol., 116: 307-312 (1985).
Yu, S., Kuo, S., “Vasorelaxant Effect of Isoliquiritigenin, A Novel Soluble Guanylate Cyclase Activator, In Rat Aorta”, Br. J. Pharmacol., 114: 1587-1594 (1995).
Gerzer, R., Bohme, E., Hofmann, F., Schultz, G., “Soluble Guanylate Cyclase Purified From Bovine Lung Contains Heme and Copper”, FEBS Lett., 132: 71-74 (1981).
Hoenicka, M., Becker, E., Apeler, H., Sirichoke, T., Schroder, H., Gerzer, R., Stasch, J., “Purified Solube Guanylyl Cyclase Expressed in a Baculovirus/Sf9 System: Stimulation by YC-1, Nitric Oxide, and Carbon Monoxide”, J. Mol. Med., 77: 14-23 (1999).
Ignarro, L., “Regulation of Cytosolic Guanylyl Cyclase By Porphyrins and Metalloporphyrins”, Adv. Pharmacol., 26: 35-65 (1994).
Mulsch, A., Bauersachs, J., Stasch, J., Busse, R., “Potentiation of Vascular Responses To No-Donors By an No-Independent Activator of Soluble Guanylyl Cyclase”, Naunyn Schmiedebergs Arch. Pharmacol: 355 R47.
Stasch, et al., “NO- and Haem-independent Activation of Soluble Guanylyl Cyclase: Molecular Basis and Cardio vascular Implications of a New Pharmacological Principle.” Brit. J. of Pharma, 136, 773-783, (2002).
Weber, et al., “The Effect of Peroxynitrate on the Catalytic Activity of Soluble Guanylyl Cyclase.,” Free Rad. Bio. & Med. 31, 1360-1367, (2001).
Pryor, et al., “The Chemistry of Peroxynitrate: A product from the Reaction of Nitric Oxide with Superoxide”, Am. J. Physiol, 268, L699-L722,(1995).
Harrison, M.D. et al., “Endothelial Function and Oxidant Stress”, Clin. Cardiol., 20, II-11-17, (1997).
Stasch, et al., “Pharmacological Actions of a Novel NO-Independent Guanylyl Cyclase Stimulator, Bay 41-8543: in vitro Studies.” Brit. J. of Pharma. 135, 333-343, (2002).
Schrammel, et al., “Characterization of 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one as a Heme-Site Inhibitor of Nitric Oxide-Sensitive Guanylyl Cyclase.” Mol. Pharmacology, 50, 1-5, (1996).
Schmidt, et al., “Mechanisms of Nitric Oxide Independent Activation of Soluble Guanylyl Cyclase,” Eur. J. Pharmacol. 468, 167-174, (2003).
Garthwaite, et al., “Potent and Selective Inhibition of Nitric Oxide-Sensitive Guanylyl Cyclase by 1H-[1,2,4]Oxadiazolo[4,3-a] quinoxalin-1-one”, Mol. Pharma, 48 184-188, (1995).
Schmidt, et al., “Identification of Residues Crucially Involved in the Binding of the Heme Moiety of Soluble Guanylate Cyclase”, J. Biol. Chem. (in press, 2003).
Mulsch et al., Circulation, 102, 11-351 (2000).
Alonso-Alija Cristina
Dembowsky Klaus
Flubacher Dietmar
Heil Markus
Naab Paul
Bayer Aktiengesellschaft
Saeed Kamal
LandOfFree
Derivatives of dicarboxylic acid having pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of dicarboxylic acid having pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of dicarboxylic acid having pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3695755